Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6501483 | 0.83 | TSHR (0.55) | L3MBTL1MAPTLMNAALDH1A1CYP2C19 | |
| SCHEMBL1605486 | 0.74 | ALDH1A1 (0.43) | L3MBTL1MAPTALDH1A1NPSR1KMT2A | |
| SCHEMBL6430640 | 0.74 | ALDH1A1 (0.40) | L3MBTL1MAPTLMNAALDH1A1HTT | |
| SCHEMBL6429808 | 0.74 | ALDH1A1 (0.43) | L3MBTL1MAPTALDH1A1NPSR1KMT2A | |
| SCHEMBL6429044 | 0.72 | ALDH1A1 (0.39) | L3MBTL1MAPTALDH1A1TSHRPOLB | |
| SCHEMBL17319219 | 0.69 | ALDH1A1 (0.59) | L3MBTL1ALDH1A1CYP2C19HTTKMT2A | |
| SCHEMBL14627991 | 0.69 | MAPT (0.56) | L3MBTL1MAPTLMNAALDH1A1NPSR1 | |
| SCHEMBL6503292 | 0.69 | ALDH1A1 (0.35) | L3MBTL1MAPTLMNAALDH1A1HTT | |
| SCHEMBL6430684 | 0.69 | ALDH1A1 (0.50) | L3MBTL1MAPTLMNAALDH1A1CYP2C19 | |
| SCHEMBL6427337 | 0.69 | ALDH1A1 (0.50) | L3MBTL1MAPTLMNAALDH1A1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050239853-A1 | New compounds | BIOVITRUM AB (SE) | 2005-10-27 | — | — | US | disclosed |
| US-20050009834-A1 | Azole compounds, process for preparation of the same and use thereof | SUMITOMO CHEMICAL TAKEDA AGRO COMPANY, LIMITED (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-1386915-A1 | AZOLE COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF | Sumitomo Chemical Takeda Agro Company, Limited (JP) | 2004-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009834-A1 | Azole compounds, process for preparation of the same and use thereof | C1S, CYP4B1, CYP4X1 | L3MBTL1 1027/4885MAPT 4519/4885LMNA 1559/4885 |
| US-20050239853-A1 | New compounds | HSD11B1, CYP11B1, HSD3B1 | L3MBTL1 4470/4885MAPT 3607/4885LMNA 1964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.